Case Reports
21 July 2015
Vol. 9 No. 4 (2015)
https://doi.org/10.4081/itjm.2015.553

Emphysematous pyelonephritis: a case report

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Diabetes mellitus, emphysematous pyelonephritis, urinary tract infection.
2187
Views
796
Downloads
561
HTML

Authors

Fabrizio Tiratterra
f.tiratterra@virgilio.it
Department of Internal Medicine, Santo Spirito Hospital, Rome, Italy.
Ludovica Feigusch
Department of Internal Medicine, Santo Spirito Hospital, Rome, Italy.
Chiara Villani
Department of Internal Medicine, Santo Spirito Hospital, Rome, Italy.
Patrizia Marchetti
Department of Internal Medicine, Santo Spirito Hospital, Rome, Italy.
Umberto Recine
Department of Internal Medicine, Santo Spirito Hospital, Rome, Italy.
Emphysematous pyelonephritis is a severe, life-threatening, necrotizing kidney disease. It occurs almost exclusively in patients with diabetes mellitus. The clinical manifestations are those of pyelonephritis such as dysuria, fever, nausea, vomiting and abdominal pain. The diagnosis is radiological. The treatment strategies are controversial. They include medical management only, percutaneous catheter drainage plus medical management, emergency nephrectomy plus medical treatment or percutaneous drainage plus medical management and emergency nephrectomy. We present the case of a 68-year-old woman affected by emphysematous pyelonephritis successfully managed with conservative medical treatment.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



Emphysematous pyelonephritis: a case report. (2015). Italian Journal of Medicine, 9(4), 370-372. https://doi.org/10.4081/itjm.2015.553

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.